Article placeholder black
Gamma frequency sensory stimulation in mild probable Alzheimer’s dementia patients: Results of feasibility and pilot studies
Article placeholder black
Gamma frequency sensory stimulation prevents brain atrophy, improves sleep and memory in probable mild Alzheimer’s patients
Research blob 1
Sensory-Evoked 40-Hz Gamma Oscillation Improves Sleep and Daily Living Activities in Alzheimer’s Disease Patients
Article placeholder black
A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer's disease
Article placeholder black
Gamma Visual Stimulation Induces a Neuroimmune Signaling Profile Distinct from Acute Neuroinflammation
Research blob 2
Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection
Research blob 3
Multi-sensory Gamma Stimulation Ameliorates Alzheimer’s-Associated Pathology and Improves Cognition
Research blob 4
Gamma frequency entrainment attenuates amyloid load and modifies microglia

Participate in a Clinical Trial

Make a real difference

Cognito Therapeutics has completed enrollment in three clinical studies to study the effectiveness of this therapy in Alzheimer’s disease. For more information on enrolling in future clinical studies involving this therapy, click below.

Backround mobile